Syed Rehan Quadery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Syed Rehan Quadery has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Jim Wild
POLARIS, Division of Clinical Medicine, School of Medicine & Population Health, Faculty of Health The University of Sheffield Sheffield UK
4 shared publications - Robin Condliffe
Sheffield Teaching Hospitals NHS Foundation Trust
4 shared publications A Charalampopolous
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publicationsAthanasios Charalampopoulos
Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publicationsC Billings
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publicationsCa Elliot
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publications
Latest Publications
- Open Access
- 20 April 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (4) , 53105
Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, chronic, progressive, and life-limiting condition with a poor five-year survival in untreated patients with advanced disease. Multi-modality imaging techniques are used in making the diagnosis and determining treatment options in CTEPH. Pulmonary endarterectomy (PEA) surgery is the treatment of choice in selected patients, providing excellent long-term survival. Balloon pulmonary angioplasty (BPA) is an established intervention for selected patients who are not suitable for surgery. Riociguat, a soluble guanylate cyclase stimulator, is a vasodilator and indicated in patients with inoperable disease. In this state-of-the-art review, we provide an update in the diagnostic evaluation with a focus on imaging modalities, treatment strategies, and future directions in CTEPH.
- 20 April 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (4) , 53105
Open AccessUpdate on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, chronic, progressive, and life-limiting condition with a poor five-year survival in untreated patients with advanced disease. Multi-modality imaging techniques are used in making the diagnosis and determining treatment options in CTEPH. Pulmonary endarterectomy (PEA) surgery is the treatment of choice in selected patients, providing excellent long-term survival. Balloon pulmonary angioplasty (BPA) is an established intervention for selected patients who are not suitable for surgery. Riociguat, a soluble guanylate cyclase stimulator, is a vasodilator and indicated in patients with inoperable disease. In this state-of-the-art review, we provide an update in the diagnostic evaluation with a focus on imaging modalities, treatment strategies, and future directions in CTEPH.
- Open Access
Impact of a Clinical Orientation Programme as perceived by new entrant international medical graduate resident doctors partaking in the programme: Results from an NHS district hospital survey
Background: International Medical Graduates (IMGs) constitute 40% of the NHS resident doctor workforce. However, there is no documented clinical orientation programme (COP) facilitating their transition into the workplace. We developed and implemented a structured COP to support new entrant IMGs. Method: Survey data was collected from new entrant IMGs in medicine who completed the COP between December 2017 and December 2019. In addition, formal feedback was collected from supervising registrars during the COP period. Data was analysed, and a framework was developed to assess impact using realist evaluation. Results: 97% (31of 32) of IMGs completed the survey. Results revealed 84% were satisfied with the programme, 81% felt confident they were prepared to begin clinical posts at completion of the programme, and 90% would recommend this programme. In addition, the overall comments from the IMGs were positive and supportive of the COP. Moreover, feedback from supervising registrars was complementary. It was seen that 87% of IMGs remained Trust employees with a mean tenure of 13 months. Of those eligible, 90% completed their annual appraisal. Conclusion: This report confirms that Trust in this COP results in a high degree of satisfaction, workforce retention and performance of new entrant IMGs. Larger scale implementation is recommended.
Open AccessImpact of a Clinical Orientation Programme as perceived by new entrant international medical graduate resident doctors partaking in the programme: Results from an NHS district hospital survey
Background: International Medical Graduates (IMGs) constitute 40% of the NHS resident doctor workforce. However, there is no documented clinical orientation programme (COP) facilitating their transition into the workplace. We developed and implemented a structured COP to support new entrant IMGs. Method: Survey data was collected from new entrant IMGs in medicine who completed the COP between December 2017 and December 2019. In addition, formal feedback was collected from supervising registrars during the COP period. Data was analysed, and a framework was developed to assess impact using realist evaluation. Results: 97% (31of 32) of IMGs completed the survey. Results revealed 84% were satisfied with the programme, 81% felt confident they were prepared to begin clinical posts at completion of the programme, and 90% would recommend this programme. In addition, the overall comments from the IMGs were positive and supportive of the COP. Moreover, feedback from supervising registrars was complementary. It was seen that 87% of IMGs remained Trust employees with a mean tenure of 13 months. Of those eligible, 90% completed their annual appraisal. Conclusion: This report confirms that Trust in this COP results in a high degree of satisfaction, workforce retention and performance of new entrant IMGs. Larger scale implementation is recommended.
- Open Access
- 31 July 2024
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 17 (3) , e74383
High dose cotrimoxazole treatment in patients with severe COVID-19: A randomised controlled trial
Background: Cotrimoxazole for severe COVID-19 may have a better prognosis because of its antibacterial, immunomodulatory, and anti-inflammatory activities. We examined the efficacy of high-dose cotrimoxazole therapy in terms of duration of hospital stays and reduction in mortality in severe COVID-19 infections. Methods: From May to November 2021, we conducted a double blind randomised controlled trial with two parallel groups in the COVID units of Bangabandhu Sheikh Mujib Medical University and Anwar Khan Modern Medical College Hospital, Dhaka. One group received standard therapy in addition to an oral dose of 960 mg of cotrimoxazole twice daily for 7 days (intervention group), while the other group received standard treatment and a placebo (standard group). Pre-protocol analysis was done. Results: A total of 188 patients were enrolled, but 166 completed the study. Of them, 93 were in the intervention group and 73 were in standard group. The mean ages of the groups were similar (intervention, 56.2 and standard, 59.2 years) (P=0.10). The mortality at 28 days between groups was also similar (11.8% in the intervention group and 15.0% in the standard group) (P=0.56). The hospital stay was 13.7 days for the intervention group and 13.5 days for the standard group (P=0.86). However, the reduction in C-reactive protein was statistically significant in the intervention group, with a mean decline of 23.6 mg/L (95% confidence interval, 0.5–46.7 mg/L). Conclusion: High-dose cotrimoxazole did not benefit in shortening in-hospital stay or reducing mortality at day 28 in patients with severe COVID-19. However, the decline in the C-reactive protein level was significant, necessitating further research.
- 31 July 2024
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 17 (3) , e74383
Open AccessHigh dose cotrimoxazole treatment in patients with severe COVID-19: A randomised controlled trial
Background: Cotrimoxazole for severe COVID-19 may have a better prognosis because of its antibacterial, immunomodulatory, and anti-inflammatory activities. We examined the efficacy of high-dose cotrimoxazole therapy in terms of duration of hospital stays and reduction in mortality in severe COVID-19 infections. Methods: From May to November 2021, we conducted a double blind randomised controlled trial with two parallel groups in the COVID units of Bangabandhu Sheikh Mujib Medical University and Anwar Khan Modern Medical College Hospital, Dhaka. One group received standard therapy in addition to an oral dose of 960 mg of cotrimoxazole twice daily for 7 days (intervention group), while the other group received standard treatment and a placebo (standard group). Pre-protocol analysis was done. Results: A total of 188 patients were enrolled, but 166 completed the study. Of them, 93 were in the intervention group and 73 were in standard group. The mean ages of the groups were similar (intervention, 56.2 and standard, 59.2 years) (P=0.10). The mortality at 28 days between groups was also similar (11.8% in the intervention group and 15.0% in the standard group) (P=0.56). The hospital stay was 13.7 days for the intervention group and 13.5 days for the standard group (P=0.86). However, the reduction in C-reactive protein was statistically significant in the intervention group, with a mean decline of 23.6 mg/L (95% confidence interval, 0.5–46.7 mg/L). Conclusion: High-dose cotrimoxazole did not benefit in shortening in-hospital stay or reducing mortality at day 28 in patients with severe COVID-19. However, the decline in the C-reactive protein level was significant, necessitating further research.
- Open Access
- 1 July 2024
- Published by Wiley in Pulmonary Circulation
- Vol. 14 (3) , e12438
The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension
Exercise training is recommended for pulmonary hypertension (PH). Post hoc analysis of the PH and Home‐Based (PHAHB) trial stratified patients into two groups based on median diffusing capacity of the lungs for carbon monoxide (DLCO). Patients with higher DLCO had a greater improvement in physical activity performance in response to exercise training, compared to those with lower DLCO. DLCO may be an important consideration in prescribing exercise in PH.
- 1 July 2024
- Published by Wiley in Pulmonary Circulation
- Vol. 14 (3) , e12438
Open AccessThe impact of gas transfer on responses to exercise training in patients with pulmonary hypertension
Exercise training is recommended for pulmonary hypertension (PH). Post hoc analysis of the PH and Home‐Based (PHAHB) trial stratified patients into two groups based on median diffusing capacity of the lungs for carbon monoxide (DLCO). Patients with higher DLCO had a greater improvement in physical activity performance in response to exercise training, compared to those with lower DLCO. DLCO may be an important consideration in prescribing exercise in PH.
- 24 February 2024
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Sotatercept in Pulmonary Arterial Hypertension
INPLASY202420104 Sotatercept in Pulmonary Arterial Hypertension Keywords: Sotatercept, Pulmonary Arterial Hypertension. Download PDF – 202420104 Download 2nd Version – This version was …
- 24 February 2024
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Sotatercept in Pulmonary Arterial Hypertension
INPLASY202420104 Sotatercept in Pulmonary Arterial Hypertension Keywords: Sotatercept, Pulmonary Arterial Hypertension. Download PDF – 202420104 Download 2nd Version – This version was …
- Open Access
- 14 March 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 840196
CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension
Providing prognostic information is important when counseling patients and planning treatment strategies in chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to assess the prognostic value of gold standard imaging of cardiac structure and function using cardiac magnetic resonance imaging (CMR) in CTEPH. Consecutive treatment-naive patients with CTEPH who underwent right heart catheterization and CMR between 2011 and 2017 were identified from the ASPIRE (Assessing-the-Specturm-of-Pulmonary-hypertensIon-at-a-REferral-center) registry. CMR metrics were corrected for age and sex where appropriate. Univariate and multivariate regression models were generated to assess the prognostic ability of CMR metrics in CTEPH. Three hundred and seventy-five patients (mean+/-standard deviation: age 64+/-14 years, 49% female) were identified and 181 (48%) had pulmonary endarterectomy (PEA). For all patients with CTEPH, left-ventricular-stroke-volume-index-%predicted (LVSVI%predicted) (p = 0.040), left-atrial-volume-index (LAVI) (p = 0.030), the presence of comorbidities, incremental shuttle walking test distance (ISWD), mixed venous oxygen saturation and undergoing PEA were independent predictors of mortality at multivariate analysis. In patients undergoing PEA, LAVI (p < 0.010), ISWD and comorbidities and in patients not undergoing surgery, right-ventricular-ejection-fraction-%predicted (RVEF%pred) (p = 0.040), age and ISWD were independent predictors of mortality. CMR metrics reflecting cardiac function and left heart disease have prognostic value in CTEPH. In those undergoing PEA, LAVI predicts outcome whereas in patients not undergoing PEA RVEF%pred predicts outcome. This study highlights the prognostic value of imaging cardiac structure and function in CTEPH and the importance of considering left heart disease in patients considered for PEA.
- 14 March 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 840196
Open AccessCMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension
Providing prognostic information is important when counseling patients and planning treatment strategies in chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to assess the prognostic value of gold standard imaging of cardiac structure and function using cardiac magnetic resonance imaging (CMR) in CTEPH. Consecutive treatment-naive patients with CTEPH who underwent right heart catheterization and CMR between 2011 and 2017 were identified from the ASPIRE (Assessing-the-Specturm-of-Pulmonary-hypertensIon-at-a-REferral-center) registry. CMR metrics were corrected for age and sex where appropriate. Univariate and multivariate regression models were generated to assess the prognostic ability of CMR metrics in CTEPH. Three hundred and seventy-five patients (mean+/-standard deviation: age 64+/-14 years, 49% female) were identified and 181 (48%) had pulmonary endarterectomy (PEA). For all patients with CTEPH, left-ventricular-stroke-volume-index-%predicted (LVSVI%predicted) (p = 0.040), left-atrial-volume-index (LAVI) (p = 0.030), the presence of comorbidities, incremental shuttle walking test distance (ISWD), mixed venous oxygen saturation and undergoing PEA were independent predictors of mortality at multivariate analysis. In patients undergoing PEA, LAVI (p < 0.010), ISWD and comorbidities and in patients not undergoing surgery, right-ventricular-ejection-fraction-%predicted (RVEF%pred) (p = 0.040), age and ISWD were independent predictors of mortality. CMR metrics reflecting cardiac function and left heart disease have prognostic value in CTEPH. In those undergoing PEA, LAVI predicts outcome whereas in patients not undergoing PEA RVEF%pred predicts outcome. This study highlights the prognostic value of imaging cardiac structure and function in CTEPH and the importance of considering left heart disease in patients considered for PEA.
- Open Access
- 9 February 2021
- Published by Springer Nature
Comparing cotrimoxazole to standard care for the treatment of severe coronavirus (COVID-19) infection in hospitalised patients
- 9 February 2021
- Published by Springer Nature
Open AccessComparing cotrimoxazole to standard care for the treatment of severe coronavirus (COVID-19) infection in hospitalised patients
- Open Access
- 10 June 2020
- Published by Elsevier in SSRN Electronic Journal
The Beneficial Effects of Oral Trimethoprim or Cotrimoxazole in Patients with Severe COVID-19: A Case Series
COVID-19 may become a critical illness which is thought to be mediated by a cytokine storm syndrome. There is no effective anti-viral treatment to date and the mainstay of treatment is supportive. We treated 22 patients with severe COVID-19 with oral trimethoprim (TMP) or cotrimoxazole (CTX) in addition to standard antibiotic therapy (ST) and compared this with 22 patients with severe COVID-19 receiving standard therapy alone. We observed that the patients with severe COVID-19 receiving TMP/CTX in addition to ST had significantly better outcomes including reduced in-patient mortality (5% versus 32%), length of hospital stay (mean, 9 versus 22 days), and the need for ventilatory support (numbers, 3 versus 16) with improved clinical parameters within 48 hours of starting treatment. This may be due to the anti-cytokine effects of TMP/CTX. Urgent clinical trials are recommended.
- 10 June 2020
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Beneficial Effects of Oral Trimethoprim or Cotrimoxazole in Patients with Severe COVID-19: A Case Series
COVID-19 may become a critical illness which is thought to be mediated by a cytokine storm syndrome. There is no effective anti-viral treatment to date and the mainstay of treatment is supportive. We treated 22 patients with severe COVID-19 with oral trimethoprim (TMP) or cotrimoxazole (CTX) in addition to standard antibiotic therapy (ST) and compared this with 22 patients with severe COVID-19 receiving standard therapy alone. We observed that the patients with severe COVID-19 receiving TMP/CTX in addition to ST had significantly better outcomes including reduced in-patient mortality (5% versus 32%), length of hospital stay (mean, 9 versus 22 days), and the need for ventilatory support (numbers, 3 versus 16) with improved clinical parameters within 48 hours of starting treatment. This may be due to the anti-cytokine effects of TMP/CTX. Urgent clinical trials are recommended.
- Open Access
- 1 June 2020
- Published by Elsevier in Future Healthcare Journal
- Vol. 7 (2) , 131-136
Innovative recruitment and clinical orientation programme to manage NHS junior doctor shortfall: A district hospital experience
Background International medical graduates (IMGs) contribute significantly towards the NHS care provision. No standardised clinical orientation programme (COP) for IMGs new to the NHS exists. Objective Our objective was to describe recruitment and retention strategies for junior doctors (JDs) in general medicine and develop a framework to anticipate outcomes of these interventions using the realist evaluation methodology. Methods We performed quality improvement interventions of recruitment and COP for new entrant IMGs in our organisation employed between December 2017 and April 2019. Results Twenty-three IMGs were recruited, 96% successfully completed the COP with a mean contract duration of 13±5 months. From the academic year 2017/18 to 2018/19, mean JD post occupancy increased from 54±3 to 73±4 JDs (p<0.001) and JD locum spend fell by £1.9 million. Conclusion Our structured COP provides a stable, trained and financially sustainable JD workforce. Application in broader NHS settings is recommended.
- 1 June 2020
- Published by Elsevier in Future Healthcare Journal
- Vol. 7 (2) , 131-136
Open AccessInnovative recruitment and clinical orientation programme to manage NHS junior doctor shortfall: A district hospital experience
Background International medical graduates (IMGs) contribute significantly towards the NHS care provision. No standardised clinical orientation programme (COP) for IMGs new to the NHS exists. Objective Our objective was to describe recruitment and retention strategies for junior doctors (JDs) in general medicine and develop a framework to anticipate outcomes of these interventions using the realist evaluation methodology. Methods We performed quality improvement interventions of recruitment and COP for new entrant IMGs in our organisation employed between December 2017 and April 2019. Results Twenty-three IMGs were recruited, 96% successfully completed the COP with a mean contract duration of 13±5 months. From the academic year 2017/18 to 2018/19, mean JD post occupancy increased from 54±3 to 73±4 JDs (p<0.001) and JD locum spend fell by £1.9 million. Conclusion Our structured COP provides a stable, trained and financially sustainable JD workforce. Application in broader NHS settings is recommended.